Core Viewpoint - The internationalization of traditional Chinese medicine (TCM) has become a national strategy, with policies supporting its global expansion, creating a golden opportunity for the industry [1] Group 1: Successful Entry into Singapore - The first overseas market for the company, Singapore, has shown exceptional commercial results, validating the feasibility of its internationalization model [2] - By July 2025, revenue from Singapore stores increased by 119% year-on-year, demonstrating rapid growth in overseas performance [2] - The high customer retention rate indicates that the company's operational system is well-received in the overseas market, providing a replicable model for future global expansion [2] Group 2: Strategic Expansion Plans - Following the successful validation in Singapore, the company has outlined a strategic path focusing on "technology + products + store expansion" for international growth [3] - The company plans to focus on the Hong Kong market in 2025 and aims to expand its Singapore clinics to over 20 by the end of 2026 [3] Group 3: Technological Innovations - The company is addressing the shortage of TCM practitioners overseas by launching AI technology that encapsulates the clinical experience of top TCM experts [4] - The AI system has achieved over 86% consistency with expert simulations, enhancing the diagnostic capabilities of overseas TCM practitioners [4] - The establishment of a TCM heritage studio in Singapore aims to train and send skilled practitioners abroad, further improving service quality [4] Group 4: Product Development and Market Penetration - The successful certification and launch of the hair care product in Singapore marks a significant milestone in the company's product internationalization efforts [5] - The company has accumulated over 22 million patient records and 18 million structured medical records, enhancing the precision and safety of its product development [5] - The certification of the hair care product provides a reusable template for future product launches overseas [6] Group 5: Store Expansion Strategies - The company plans to adopt a mixed strategy for store expansion, combining self-built flagship stores, strategic partnerships, and acquisitions to enhance market penetration [6] - Self-built flagship stores will establish brand recognition and serve as a model for regional expansion [6] - Collaborations with local medical institutions will leverage existing customer bases, while acquisitions of quality clinics will create a differentiated competitive advantage [6] Group 6: Future Outlook - The company is moving towards becoming a global brand in TCM, with a closed-loop strategy of service expansion, cost reduction through technology, and profitability through product offerings [6] - The ongoing expansion into the Hong Kong market and the establishment of 20 clinics in Singapore are expected to solidify the company's position in the global TCM sector [6]

Core Viewpoint - Dongyangguang has been recognized as the "global pioneer in ecological breeding of Cordyceps" by Frost & Sullivan, affirming its leading position in the industry after 18 years of development in the Cordyceps sector [1] Group 1: Research and Development - The wild Cordyceps is primarily found in high-altitude areas (3500-5000 meters), and its production has significantly decreased due to overharvesting and climate change, leading to a resource crisis in the industry [3] - Dongyangguang initiated an ecological breeding program in 2007, investing over 4 billion yuan and employing more than 260 researchers to innovate across the entire industry chain [3] - The company has established a key laboratory for Cordyceps breeding and product research, recognized by the National Administration of Traditional Chinese Medicine [3] Group 2: Technological Innovation - The market for Cordyceps in China has surpassed 70 billion yuan, but challenges such as lack of industry standards and product quality inconsistencies hinder industry upgrades [6] - Dongyangguang has developed proprietary technologies to enhance product quality, ensuring that each batch of Cordyceps retains 2.7 times the SOD activity compared to traditional drying methods [6] - The company emphasizes quality control, achieving zero additives and significantly lower heavy metal content than regulatory limits [6] Group 3: Global Expansion - Dongyangguang is actively pursuing a global strategy while solidifying its domestic market presence, investing hundreds of millions in brand penetration [9] - The company has established over 350 brand stores in more than 150 cities, enhancing its reach to health-conscious consumers [12] - Dongyangguang is also expanding internationally, with plans for an overseas flagship store and participation in international forums to promote its brand [12][14]

Core Viewpoint - The conference on high-quality development of traditional Chinese medicine (TCM) highlighted the strategic layout of Guoshengtang in promoting the internationalization of TCM through "management empowerment + AI technology + products" to establish itself as the leading TCM health brand for the global Chinese community [1] Group 1: Management Expansion - Guoshengtang's acquisition of Singapore's Baozhongtang in March 2024 marks the beginning of its internationalization journey, achieving a revenue growth of 119% year-on-year by July 2025 [2] - The company plans to expand to 30 clinics in Singapore by the end of 2026, leveraging its mature domestic operational model [2] - Guoshengtang employs a multi-faceted strategy for overseas expansion, including self-built flagship stores, strategic partnerships with local TCM institutions, and acquisitions of quality Western medical clinics and hospitals [2] Group 2: AI Technology Deployment - The launch of 10 AI avatars of renowned TCM doctors addresses the shortage of quality TCM talent overseas, facilitating online follow-up consultations [4] - The AI avatars have achieved over 86% consistency in expert simulation, receiving high praise for their diagnostic accuracy and medication rationality [4][5] - The AI technology not only enhances domestic operations but also plays a crucial role in the company's international endeavors, breaking down barriers in the distribution of TCM talent [5] Group 3: Product Internationalization - Guoshengtang has made significant strides in the development of innovative TCM products, with its first self-developed TCM product receiving certification from Singapore's Health Sciences Authority [6] - The company is collaborating with Huaxi Hospital and Baidu to establish a clinical evaluation platform for TCM, aiming to address challenges in real-world data assessment [6] - Guoshengtang has accumulated extensive high-quality TCM data over 10 years, including over 17 million consultation records and 8 million medical records, which supports its innovative drug development efforts [6] Group 4: Future Outlook - The company aims to enhance its research and development of TCM formulations, creating a robust platform for innovative TCM services [7] - By integrating traditional TCM with modern technology, Guoshengtang is making significant progress towards its goal of becoming the global leading TCM brand for the Chinese community [7]

Core Viewpoint - The conference on high-quality development of traditional Chinese medicine (TCM) highlighted the strategic layout of Guoshengtang in promoting the internationalization of TCM through "management empowerment + AI technology + products" to establish itself as the leading TCM health brand for the global Chinese community [1] Group 1: Management Strategy - Guoshengtang has initiated its internationalization journey by acquiring Singapore's Baozhongtang, achieving a revenue increase of 119% year-on-year by July 2025 [1] - The company plans to expand to 30 clinics in Singapore by the end of 2026, leveraging its successful operational model from China [1] - The company employs a multi-faceted strategy for overseas expansion, including self-built flagship stores, strategic partnerships, and acquisitions of local medical institutions [2] Group 2: AI Technology - Guoshengtang launched 10 AI avatars of renowned TCM doctors to address the shortage of quality TCM talent overseas, enhancing the internationalization of TCM [2][3] - The AI avatars have achieved over 86% consistency with expert simulations, improving diagnostic accuracy and medication rationality [4] - The AI technology aids in alleviating the scarcity of quality TCM resources and enhances the efficiency of top experts, while also supporting the training of younger doctors [4] Group 3: Product Development - Guoshengtang has made significant advancements in the development of traditional Chinese medicine (TCM) products, with its first proprietary TCM product receiving certification in Singapore [5][6] - The company has initiated a project to create an integrated platform for clinical evaluation of TCM, leveraging AI and big data to enhance clinical research and innovation [6] - Guoshengtang aims to strengthen its product development efforts, focusing on innovative TCM formulations and ensuring the legacy of renowned TCM practitioners through its products [7]

Core Points - The 2025 China International Service Trade Fair (CIFTIS) will be held from September 10 to 14 in Beijing, focusing on health and wellness services with the theme "Intelligent Leading the Future, Healthy Living" [1] - The event will feature two main exhibition areas: "Intelligent Therapy Cloud Matrix" and "Universal Health Service Matrix," showcasing innovative products that integrate artificial intelligence and healthcare [2][3] - The fair will host nearly 20 conferences and forums, including the Capital International Medical Conference, discussing topics such as technological innovation, healthcare industry development, and international cooperation [4] Exhibition Highlights - The health service exhibition will include advanced technology products with a 54% participation rate from Fortune 500 and industry-leading companies, and a 53% international participation rate [2] - The "Intelligent Therapy Cloud Matrix" will present a comprehensive display of 15 stages in the AI-driven biomedical research and development process, highlighting case studies in AI diagnostics and data monitoring [2] - The "Universal Health Service Matrix" will focus on health management, elderly care, and traditional Chinese medicine, featuring lectures on topics like weight management and mental health [3] Conference and Activities - The Capital International Medical Conference will include keynote speeches and parallel forums with renowned experts discussing various healthcare topics [4] - The event will also feature significant activities such as the launch of the "2025 CIFTIS Health and Wellness Service Innovation Achievements" and the "Seventh Technology Innovation Competition" [4] - The fair will emphasize the "Beijing Service" brand, showcasing innovative practices and applications in the healthcare sector [3] Traditional Chinese Medicine Focus - The TCM theme at the fair will have 48 participating institutions, with a record 48% representation from leading organizations [5] - Innovative experiences such as the "AI TCM Future Clinic" and a small-scale meridian conditioning robot will be showcased [5] - Cultural exchange activities will include TCM forums and a "24 Solar Terms Health Check-in" event to enhance public engagement [6]

中国驻瑞典大使崔爱民与瑞典北京同仁堂工作人员合影。中国驻瑞典大使馆供图 崔爱民表示，中医药根植于中华传统优秀文化，体现着中国人的健康理念，是长期临床实践积累形成的诊疗保健体系，推动了东西方文明交流互鉴， 为人类健康事业作出了贡献。希望大家立足当地、因地制宜，扩大中医药文化影响力，探索中华传统医学与现代医学有机结合的新形式、新常态，增进中 瑞两国人民友好，为构建人类卫生健康共同体作出更大贡献。 人民网斯德哥尔摩8月12日电 （记者殷淼）8月12日，中国驻瑞典大使崔爱民走访瑞典北京同仁堂和Norden Kinamedicin等中医药诊疗保健机构，实地 了解中医药在瑞发展情况，并就推动中医药发展国际化进行交流。中国驻瑞典大使馆负责科技事务的参赞崔玉亭和领侨处主任杨冠达陪同参加了有关活 动。 中国驻瑞典大使崔爱民与瑞典Norden Kinamedicin工作人员合影。中国驻瑞典大使馆供图 有关机构负责人表示，将加强与瑞典当地民众的交流互动，不断弘扬中医药文化，进一步展示中医药独特魅力。 ...

Group 1 - The Tsinghua University initiative "Liangshan Journey" was launched on August 4, with 43 outstanding teachers and students participating in social practice in Liangshan [1] - Participants visited Haoyisheng Panxi Pharmaceutical to understand its production and operational status, highlighting Liangshan's unique resource advantages and the development of traditional Chinese medicine [5][6] - Haoyisheng's product, Kangfu New Liquid, achieved over 1 billion yuan in annual sales and became the first traditional Chinese medicine to receive certification from Health Canada, showcasing the internationalization of Chinese medicine [8] Group 2 - The company integrates traditional Chinese medicine with modern technology, establishing research platforms and collaborating with multiple universities to drive innovation [6][9] - The digital and intelligent breeding of American cockroaches is showcased, with 22 billion cockroaches being raised in a controlled environment to ensure safety and stability of raw materials [9] - The digitalized production line for Kangfu New Liquid employs smart systems for precise control, enhancing production capacity and quality, contributing to the high-quality development of Liangshan's pharmaceutical industry [9]

Core Points - The forum titled "Integration of Industry, Academia, and Research on Classic Chinese Medicine Formulas" was held in Zhuhai, focusing on the internationalization of traditional Chinese medicine (TCM) [1][3] - The project "Pharmacological Verification and Formulation Optimization of Classic Formulas Huangqi Guizhi Wuwu Decoction and Taohong Siwu Decoction" was officially launched during the forum [1][21] - The event was co-hosted by the Macau University of Science and Technology and Beijing Tongrentang Group, highlighting the collaboration between academia and industry [1][3] Industry Development - The forum aimed to promote the industrialization and academic research of classic TCM formulas, facilitating cross-border exchanges [1][3] - Experts discussed the current state of the TCM industry and the development practices of classic formulas, providing strategies for modernization and internationalization [9][13] - The project received funding of over 12 million Macanese Patacas from the Macao SAR government, indicating strong governmental support for TCM development [21] Collaboration and Future Prospects - The collaboration between Macau University of Science and Technology and Tongrentang Group is seen as a significant step towards modernizing and internationalizing TCM [5][28] - The forum included discussions on the advantages of the Hong Kong-Macao TCM industry and the role of modern technology in TCM research [24][26] - Future efforts will focus on enhancing the international influence of the Tongrentang brand and expanding its market presence globally [7][28]

Core Themes - The third China International Supply Chain Promotion Expo (Chain Expo) was held in Beijing, focusing on six major chains including advanced manufacturing, clean energy, smart automotive, digital technology, health living, and green agriculture [1] - Over 650 enterprises and institutions from 75 countries and regions participated, with foreign exhibitors accounting for 35% [1] Company Highlights - Yiling Pharmaceutical showcased its achievements in promoting high-quality development in traditional Chinese medicine (TCM) through solidifying the industrial chain, activating the innovation chain, and extending the health chain [3] - Yiling Pharmaceutical emphasized strict quality control of Chinese medicinal materials, establishing over 60 cultivation bases across the country, which also helps local farmers increase their income [4] - The company presented patented new drugs and innovative products in the health sector, including the Ba Zi Bu Shen capsule, which focuses on anti-aging applications [4] - Yiling Pharmaceutical aims to enhance the internationalization of TCM, with a product distribution map covering over 50 countries and regions [5] Industry Innovations - Guangzhou Pharmaceutical Group, the first TCM company to enter the Fortune Global 500, demonstrated its innovative practices in the TCM supply chain through a digital ecosystem, research innovation, and smart logistics [6] - The group has established nearly 90 standardized planting bases and has implemented blockchain technology for traceability and quality control, achieving a 148% increase in production capacity and a 289% increase in efficiency [6] - Sanofi highlighted its 30 years of localization in China, showcasing its high-quality manufacturing capabilities and a comprehensive immunization service chain [7][8] - GE Healthcare presented its latest high-end medical equipment and announced the establishment of a green supply chain innovation ecosystem alliance to promote sustainable practices in the medical device industry [9] - Steady Medical emphasized its commitment to reducing environmental pollution and introduced a new series of medical beauty products aimed at protecting public health [10]

Core Viewpoint - The article highlights the journey of Christin Masseli, a German practitioner of Traditional Chinese Medicine (TCM), who has dedicated over 10 years to studying and practicing TCM in China, promoting its principles and practices to a global audience [4][5][8]. Group 1: Background and Education - Christin Masseli's interest in TCM began in childhood, influenced by her family's tradition of using herbal remedies in Germany [4]. - After obtaining a law degree in Germany, she decided to pursue her passion for TCM, moving to Beijing to study at Beijing University of Chinese Medicine in 2014 [5][6]. - Despite initial challenges, including language barriers and health issues, she persevered and developed a deep understanding of TCM principles and practices [6][7]. Group 2: Practice and Philosophy - Masseli emphasizes the importance of treating all patients equally, regardless of their background, reflecting the core TCM philosophy of compassion and care [6][7]. - She employs a personalized approach to treatment, focusing on understanding each patient's unique condition and history [6][8]. - Masseli actively communicates the principles of TCM to her patients, using relatable explanations to bridge cultural differences [8][9]. Group 3: Cultural Promotion and Training - In addition to her clinical practice, Masseli is involved in promoting TCM culture through workshops and training sessions for foreigners interested in learning about TCM [8][9]. - She has organized cultural exchange events to introduce TCM concepts to international audiences, highlighting its holistic health benefits [8][9]. - Masseli's efforts contribute to the internationalization of TCM, with data indicating its presence in approximately 200 countries and regions worldwide [9].